T淋巴细胞、炎症细胞因子与卵巢子宫内膜异位症的相关性及诊断价值
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Research on the correlation and diagnostic value of T lymphocyte and inflammatory cytokines in peripheral blood to ovarian endometriosis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨外周血中T淋巴细胞、炎症细胞因子与卵巢子宫内膜异位症(OMs)的相关性及诊断价值。方法 选取2020年 10月—2022年6月我院收治行开腹或腹腔镜手术经病理确诊OMs患者72例为观察组,根据修正子宫内膜异位症分期(r-AFS)分为I~II期37例,III~IV期35例,另选取同期术后诊断为单纯性卵巢囊肿或良性畸胎瘤的患者72例为对照组。利用流式细胞检测法检测外周血中T淋巴细胞(CD4+、CD8+、CD4+/CD8+)、炎症细胞因子(IL-2、IL-4、IL-6、IL-10、IL-17A、IFN-γ和TNF-α含量),收集相关临床资料进行单因素及Logistic多因素回归分析讨论OMs影响因素, I~II、III~IV期EMs患者中比较外周血独立影响指标CD4+、TNF-α表达差异。ROC曲线评估CD4+、CD8+和TNF-α 3项指标单独及联合对OMs的诊断效能。结果 CD8+、IL-2、IL6、IL-10、TNF-α、月经初潮年龄<13岁,经期天数>6天、痛经、人流手术或宫腔操作史和剖宫产史为OMs危险因素,CD4+及CD4+/CD8+为OMs保护因素;CD8+、TNF-α、经期天数>6天、痛经和人流手术或宫腔操作史为OMs独立危险因素,CD4+为OMs独立保护因素;I~II、III~IV期OMs CD4+、CD8+和TNF-α差异有统计学意义(P<0.05);CD4+、CD8+与TNF-α联合检测可提高OMs诊断效能。结论 外周血T淋巴细胞亚群、炎症细胞因子在OMs发生中发挥着一定作用,CD4+、CD8+和TNF-α参与疾病进展且3者联合检测在OMs诊断方面可能具有较高应用价值

    Abstract:

    Objective To explore the correlation and diagnostic value of T lymphocyte, inflammatory cytokines in peripheral blood to ovarian endometriosis (OMs). Methods From October 2020 to June 2022, 72 patients with pathologically confirmed OMs undergoing open or laparoscopic surgery were admitted to the case group, 37 patients were divided into stage I-II and there were 35 patients in stage III-IV according to the modified endometriosis stage (r-AFS). 72 patients with Simple cyst or benign teratomas after the same period of surgery were selected as control group. Flow cytometry was used to detect CD4+, CD8+, CD4+/CD8+, IL-2, IL-4, IL-6, IL-10, IL-17A, IFN-γ and TNF-α in peripheral blood and gather related clinical data by univariate and logistic multivariate regression analysis to discuss the influencing factors of EMs. Patients in stage of I-II and II-IV in OMs were further compared with CD4+, CD8+ and TNF-α which were independent influencing in the peripheral blood indexes express differences. The ROC curve evaluates the diagnostic efficacy of OMs by three indicators, both individually and in combination. Results CD8+, IL-2, IL6, IL-10, TNF-α, menarche age<13 years, menstrual period days>6 days, dysmenorrhea, abortion surgery or cervical surgery history and caesarean section history were OMs risk factors, CD4+ and CD4+/CD8+ were OMs protection factors. CD8+, TNF-α, menstrual period>6 days, dysmenorrhea, abortion surgery or hysteresis surgery and uterine surgery history were independent risk factors for OMs, and CD4+ was an independent protective factor for OMs. There were Significant differences between stage I-II and III-IV of OMs in CD4+, CD8+ and TNF-α (P<0.05). The combined detection of CD4+, CD8+ and TNF-α could improve the diagnostic efficiency of OMs. Conclusion T lymphocyte subsets and inflammatory cytokines Peripheral blood play a role in the occurrence of OMs, CD4+, CD8+ and TNF-α are involved in disease progression and the combined detection of the three may have high application value in the diagnosis of OMs

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-07-18
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司